Skip to main content
Erschienen in: The Journal of Behavioral Health Services & Research 3/2014

01.07.2014

A Preliminary 6-Month Prospective Study Examining Self-reported Religious Preference, Religiosity/Spirituality, and Retention at a Jewish Residential Treatment Center for Substance-Related Disorders

verfasst von: Iman Parhami, MD, MPH, Margarit Davtian, MA, Michael Collard, MA, Jean Lopez, BSc, Timothy W. Fong, MD

Erschienen in: The Journal of Behavioral Health Services & Research | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Although there is a substantial amount of research suggesting that higher levels of religiosity/spirituality (R/S) are associated with better treatment outcomes of substance-related disorders, no studies have explored this relationship at a faith-based residential treatment center. The objective of this prospective study is to explore the relationship between R/S, self-reported religious preference, and retention at a Jewish residential treatment center for substance-related disorders. Using the Daily Spiritual Experience Scale, R/S levels were assessed for 33 subjects at baseline, 1 month, 3 months, and 6 months. Results demonstrated a significant relationship between baseline R/S level and retention at 6 months, while R/S levels were unchanged during the course of treatment. Notably, no relationship was found between self-reported religious affiliation and retention. This study demonstrates that patients’ R/S level, rather than religious affiliation, is a possible predictor for better outcome at faith-based residential centers for substance-related disorders.
Literatur
1.
Zurück zum Zitat Brizer DA. Religiosity and drug abuse among psychiatric inpatients. The American Journal of Drug and Alcohol Abuse 1993; 19(3): 337–345.PubMedCrossRef Brizer DA. Religiosity and drug abuse among psychiatric inpatients. The American Journal of Drug and Alcohol Abuse 1993; 19(3): 337–345.PubMedCrossRef
2.
Zurück zum Zitat Pardini DA, Plante TG, Sherman A, et al. Religious faith and spirituality in substance abuse recovery: Determining the mental health benefits. Journal of Substance Abuse Treatment 2000; 19(4): 347–354.PubMedCrossRef Pardini DA, Plante TG, Sherman A, et al. Religious faith and spirituality in substance abuse recovery: Determining the mental health benefits. Journal of Substance Abuse Treatment 2000; 19(4): 347–354.PubMedCrossRef
3.
Zurück zum Zitat Gorsuch RL. Religious aspects of substance abuse and recovery. Journal of Social Issues 1995; 51(2): 65–83.CrossRef Gorsuch RL. Religious aspects of substance abuse and recovery. Journal of Social Issues 1995; 51(2): 65–83.CrossRef
4.
Zurück zum Zitat Avants SK, Warburton LA, Margolin A. Spiritual and religious support in recovery from addiction among HIV-positive injection drug users. Journal of Psychoactive Drugs 2001; 33(1): 39–45.PubMedCrossRef Avants SK, Warburton LA, Margolin A. Spiritual and religious support in recovery from addiction among HIV-positive injection drug users. Journal of Psychoactive Drugs 2001; 33(1): 39–45.PubMedCrossRef
5.
Zurück zum Zitat Koenig HG, McCullough ME, Larson DB. Handbook of religion and health. Oxford University Press, USA; 2001.CrossRef Koenig HG, McCullough ME, Larson DB. Handbook of religion and health. Oxford University Press, USA; 2001.CrossRef
6.
Zurück zum Zitat Grettenberger SE, Bartkowski JP, Smith SR. Evaluating the effectiveness of faith-based we agencies: Methodological challenges and possibilities. Journal of Religion & Spirituality in Social Work 2006; 25(3–4): 223–240.CrossRef Grettenberger SE, Bartkowski JP, Smith SR. Evaluating the effectiveness of faith-based we agencies: Methodological challenges and possibilities. Journal of Religion & Spirituality in Social Work 2006; 25(3–4): 223–240.CrossRef
7.
Zurück zum Zitat Paloutzian RF, Kirkpatrick LA. Introduction: The scope of religious influences on personal and societal well being. Journal of Social Issues 1995; 51(2): 1–11.CrossRef Paloutzian RF, Kirkpatrick LA. Introduction: The scope of religious influences on personal and societal well being. Journal of Social Issues 1995; 51(2): 1–11.CrossRef
8.
Zurück zum Zitat Longshore D, Anglin MD, Conner BT. Are religiosity and spirituality useful constructs in drug treatment research? The Journal of Behavioral Health Services and Research 2009; 36(2): 177–188.PubMedCrossRef Longshore D, Anglin MD, Conner BT. Are religiosity and spirituality useful constructs in drug treatment research? The Journal of Behavioral Health Services and Research 2009; 36(2): 177–188.PubMedCrossRef
9.
Zurück zum Zitat Underwood L. Ordinary spiritual experience: Qualitative research, interpretive guidelines, and population distribution for the Daily Spiritual Experience Scale. Archive for the Psychology of Religion 2006; 28(1): 181–218.CrossRef Underwood L. Ordinary spiritual experience: Qualitative research, interpretive guidelines, and population distribution for the Daily Spiritual Experience Scale. Archive for the Psychology of Religion 2006; 28(1): 181–218.CrossRef
10.
Zurück zum Zitat Kirkwood W. Studying communication about spirituality and the spiritual consequences of communication. Journal of Communication and Religion 1994; 17(1): 13–26. Kirkwood W. Studying communication about spirituality and the spiritual consequences of communication. Journal of Communication and Religion 1994; 17(1): 13–26.
11.
Zurück zum Zitat Thoresen CE, Harris AHS, Oman D. Spirituality, religion, and health. In: TG Plante (Ed). Faith and Health: Psychological Perspectives. New York: The Guildford Press, 2001, pp15–52. Thoresen CE, Harris AHS, Oman D. Spirituality, religion, and health. In: TG Plante (Ed). Faith and Health: Psychological Perspectives. New York: The Guildford Press, 2001, pp15–52.
12.
Zurück zum Zitat Hill PC, Pargament KI. Advances in the conceptualization and measurement of religion and spirituality: Implications for physical and mental health research. Psychology of Religion and Spirituality 2008; S(1): 3–17. Hill PC, Pargament KI. Advances in the conceptualization and measurement of religion and spirituality: Implications for physical and mental health research. Psychology of Religion and Spirituality 2008; S(1): 3–17.
13.
Zurück zum Zitat Pargament KI, Park CL. In times of stress: The religion–coping connection. In: B Spilka, DN McIntosh (Eds). The Psychology of Religion: Theoretical Approaches. Boulder: Westview Press. 1997, pp43–53. Pargament KI, Park CL. In times of stress: The religion–coping connection. In: B Spilka, DN McIntosh (Eds). The Psychology of Religion: Theoretical Approaches. Boulder: Westview Press. 1997, pp43–53.
14.
Zurück zum Zitat Poloma MM, Pendleton BF. Exploring types of prayer and quality of life: A research note. Review of Religious Research 1989; 46–53. Poloma MM, Pendleton BF. Exploring types of prayer and quality of life: A research note. Review of Religious Research 1989; 46–53.
15.
Zurück zum Zitat Stanley MA, Bush AL, Camp ME, et al. Older adults’ preferences for religion/spirituality in treatment for anxiety and depression. Aging & Mental Health 2011; 15(3): 334–343.CrossRef Stanley MA, Bush AL, Camp ME, et al. Older adults’ preferences for religion/spirituality in treatment for anxiety and depression. Aging & Mental Health 2011; 15(3): 334–343.CrossRef
16.
Zurück zum Zitat Gorsuch RL, Butler MC. Initial drug abuse: A review of predisposing social psychological factors. Psychological Bulletin 1976; 83(1): 120–137.PubMedCrossRef Gorsuch RL, Butler MC. Initial drug abuse: A review of predisposing social psychological factors. Psychological Bulletin 1976; 83(1): 120–137.PubMedCrossRef
17.
Zurück zum Zitat Kendler KS, Gardner CO, Prescott CA. Religion, psychopathology, and substance use and abuse; a multimeasure, genetic-epidemiologic study. American Journal of Psychiatry 1997; 154(3): 322–329.PubMed Kendler KS, Gardner CO, Prescott CA. Religion, psychopathology, and substance use and abuse; a multimeasure, genetic-epidemiologic study. American Journal of Psychiatry 1997; 154(3): 322–329.PubMed
18.
Zurück zum Zitat Larson DB, Larson SB. Spirituality's potential relevance to physical and emotional health: A brief review of quantitative research. Journal of Psychology and Theology 2003; 31(1): 37–52. Larson DB, Larson SB. Spirituality's potential relevance to physical and emotional health: A brief review of quantitative research. Journal of Psychology and Theology 2003; 31(1): 37–52.
19.
Zurück zum Zitat Mathew RJ, Georgi J, Wilson WH, et al. A retrospective study of the concept of spirituality as understood by recovering individuals. Journal of Substance Abuse Treatment 1996; 13(1): 67–73.PubMedCrossRef Mathew RJ, Georgi J, Wilson WH, et al. A retrospective study of the concept of spirituality as understood by recovering individuals. Journal of Substance Abuse Treatment 1996; 13(1): 67–73.PubMedCrossRef
20.
Zurück zum Zitat Miller WR. Researching the spiritual dimensions of alcohol and other drug problems. Addiction 1998; 93(7): 979–990.PubMedCrossRef Miller WR. Researching the spiritual dimensions of alcohol and other drug problems. Addiction 1998; 93(7): 979–990.PubMedCrossRef
22.
Zurück zum Zitat Neff JA, Shorkey CT, Windsor LC. Contrasting faith-based and traditional substance abuse treatment programs. Journal of Substance Abuse Treatment 2006; 30(1): 49–61.PubMedCrossRef Neff JA, Shorkey CT, Windsor LC. Contrasting faith-based and traditional substance abuse treatment programs. Journal of Substance Abuse Treatment 2006; 30(1): 49–61.PubMedCrossRef
23.
Zurück zum Zitat Zhang Z, Friedmann PD, Gerstein DR. Does retention matter? Treatment duration and improvement in drug use. Addiction 2003; 98(5): 673–684.PubMedCrossRef Zhang Z, Friedmann PD, Gerstein DR. Does retention matter? Treatment duration and improvement in drug use. Addiction 2003; 98(5): 673–684.PubMedCrossRef
24.
Zurück zum Zitat Simpson D, Joe GW, Rowan-Szal GA. Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence 1997; 47(3): 227–235.PubMedCrossRef Simpson D, Joe GW, Rowan-Szal GA. Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence 1997; 47(3): 227–235.PubMedCrossRef
25.
Zurück zum Zitat Simpson DD. Treatment for drug abuse. Follow-up outcomes and length of time spent. Archives of General Psychiatry 1981; 38(8): 875–880. Simpson DD. Treatment for drug abuse. Follow-up outcomes and length of time spent. Archives of General Psychiatry 1981; 38(8): 875–880.
26.
Zurück zum Zitat Stark M. Dropping out of substance abuse treatment: A clinically oriented review. Clinical Psychology Review 1992; 12(1): 93–116.CrossRef Stark M. Dropping out of substance abuse treatment: A clinically oriented review. Clinical Psychology Review 1992; 12(1): 93–116.CrossRef
27.
Zurück zum Zitat Messina N, Wish E, Nemes S. Predictors of treatment outcomes in men and women admitted to a therapeutic community. The American Journal of Drug and Alcohol Abuse 2000; 26(2): 207–227.PubMedCrossRef Messina N, Wish E, Nemes S. Predictors of treatment outcomes in men and women admitted to a therapeutic community. The American Journal of Drug and Alcohol Abuse 2000; 26(2): 207–227.PubMedCrossRef
28.
Zurück zum Zitat Mulder RT, Frampton C, Peka H, et al. Predictors of 3-month retention in a drug treatment therapeutic community. Drug and Alcohol Review 2009; 28(4): 366–371.PubMedCrossRef Mulder RT, Frampton C, Peka H, et al. Predictors of 3-month retention in a drug treatment therapeutic community. Drug and Alcohol Review 2009; 28(4): 366–371.PubMedCrossRef
29.
Zurück zum Zitat Lecrubier Y, Sheehan D, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. European Psychiatry 1997; 12(5): 224–231.CrossRef Lecrubier Y, Sheehan D, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. European Psychiatry 1997; 12(5): 224–231.CrossRef
30.
Zurück zum Zitat Sheehan D, Lecrubier Y, Harnett Sheehan K, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. European Psychiatry 1997; 12(5): 232–241CrossRef Sheehan D, Lecrubier Y, Harnett Sheehan K, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. European Psychiatry 1997; 12(5): 232–241CrossRef
31.
Zurück zum Zitat Sheehan D, Lecrubier Y, Sheehan K, et al. The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998; 59:22–33. Sheehan D, Lecrubier Y, Sheehan K, et al. The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998; 59:22–33.
32.
Zurück zum Zitat Hasin DS, Stinson FS, Ogburn E, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 2007; 64(7): 830–842.PubMedCrossRef Hasin DS, Stinson FS, Ogburn E, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 2007; 64(7): 830–842.PubMedCrossRef
33.
Zurück zum Zitat McGovern MP, Xie H, Segal SR, et al. Addiction treatment services and co-occurring disorders: Prevalence estimates, treatment practices, and barriers. Journal of Substance Abuse Treatment 2006; 31(3): 267–275.PubMedCrossRef McGovern MP, Xie H, Segal SR, et al. Addiction treatment services and co-occurring disorders: Prevalence estimates, treatment practices, and barriers. Journal of Substance Abuse Treatment 2006; 31(3): 267–275.PubMedCrossRef
34.
Zurück zum Zitat Broome KM, Flynn PM, Simpson DD. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Services Research 1999; 34(3): 791–806.PubMedCentralPubMed Broome KM, Flynn PM, Simpson DD. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Services Research 1999; 34(3): 791–806.PubMedCentralPubMed
35.
Zurück zum Zitat Nomamiukor N, Brown ES. Attrition factors in clinical trials of comorbid bipolar and substance-related disorders. Journal of Affective Disorders 2009; 112(1–3): 284–288.PubMedCrossRef Nomamiukor N, Brown ES. Attrition factors in clinical trials of comorbid bipolar and substance-related disorders. Journal of Affective Disorders 2009; 112(1–3): 284–288.PubMedCrossRef
36.
Zurück zum Zitat McLellan AT, Kushner H, Metzger D, et al. The Fifth Edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 1992; 9(3): 199–213.PubMedCrossRef McLellan AT, Kushner H, Metzger D, et al. The Fifth Edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 1992; 9(3): 199–213.PubMedCrossRef
37.
Zurück zum Zitat Mäkelä K. Studies of the reliability and validity of the Addiction Severity Index. Addiction 2004; 99(4): 398–410.PubMedCrossRef Mäkelä K. Studies of the reliability and validity of the Addiction Severity Index. Addiction 2004; 99(4): 398–410.PubMedCrossRef
38.
Zurück zum Zitat Smith KW, Larson MJ. Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. The American Journal of Drug and Alcohol Abuse 2003; 29(2): 323–335. Smith KW, Larson MJ. Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. The American Journal of Drug and Alcohol Abuse 2003; 29(2): 323–335.
39.
Zurück zum Zitat Field CA, Adinoff B, Harris TR, et al. Construct, concurrent and predictive validity of the URICA: Data from two multi-site clinical trials. Drug and Alcohol Dependence 2009; 101(1–2): 115–123.PubMedCentralPubMedCrossRef Field CA, Adinoff B, Harris TR, et al. Construct, concurrent and predictive validity of the URICA: Data from two multi-site clinical trials. Drug and Alcohol Dependence 2009; 101(1–2): 115–123.PubMedCentralPubMedCrossRef
40.
Zurück zum Zitat Field CA, Duncan J, Washington K, et al. Association of baseline characteristics and motivation to change among patients seeking treatment for substance dependence. Drug and Alcohol Dependence 2007; 91(1): 77–84.PubMedCrossRef Field CA, Duncan J, Washington K, et al. Association of baseline characteristics and motivation to change among patients seeking treatment for substance dependence. Drug and Alcohol Dependence 2007; 91(1): 77–84.PubMedCrossRef
41.
Zurück zum Zitat Underwood L, Teresi J. The Daily Spiritual Experience Scale: Development, theoretical description, reliability, exploratory factor analysis, and preliminary construct validity using health-related data. Annals of Behavioral Medicine 2002; 24(1): 22–33.PubMedCrossRef Underwood L, Teresi J. The Daily Spiritual Experience Scale: Development, theoretical description, reliability, exploratory factor analysis, and preliminary construct validity using health-related data. Annals of Behavioral Medicine 2002; 24(1): 22–33.PubMedCrossRef
42.
Zurück zum Zitat Underwood LG. The Daily Spiritual Experience Scale: Overview and results. Religions 2011; 2(1): 29–50.CrossRef Underwood LG. The Daily Spiritual Experience Scale: Overview and results. Religions 2011; 2(1): 29–50.CrossRef
43.
Zurück zum Zitat Robinson EA, Cranford JA, Webb JR, et al. Six-month changes in spirituality, religiousness, and heavy drinking in a treatment-seeking sample. Journal of Studies on Alcohol and Drugs 2007; 68(2): 282–290.PubMed Robinson EA, Cranford JA, Webb JR, et al. Six-month changes in spirituality, religiousness, and heavy drinking in a treatment-seeking sample. Journal of Studies on Alcohol and Drugs 2007; 68(2): 282–290.PubMed
44.
Zurück zum Zitat Zemore SE, Kaskutas LA. Helping, spirituality and alcoholics anonymous in recovery. Journal of Studies on Alcohol 2004; 65(383–391. Zemore SE, Kaskutas LA. Helping, spirituality and alcoholics anonymous in recovery. Journal of Studies on Alcohol 2004; 65(383–391.
45.
Zurück zum Zitat Flynn P, Craddock S, Hubbard R, et al. Methodological overview and research design for the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 1997; 11(4): 230–243.CrossRef Flynn P, Craddock S, Hubbard R, et al. Methodological overview and research design for the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 1997; 11(4): 230–243.CrossRef
46.
Zurück zum Zitat Shao J, Zhong B. Last observation carry-forward and last observation analysis. Statistics in Medicine 2003; 22(15): 2429–2441.PubMedCrossRef Shao J, Zhong B. Last observation carry-forward and last observation analysis. Statistics in Medicine 2003; 22(15): 2429–2441.PubMedCrossRef
47.
Zurück zum Zitat Heinz A, Epstein DH, Preston KL. Spiritual/religious experiences and in-treatment outcome in an inner-city program for heroin and cocaine dependence. Journal of Psychoactive Drugs 2007; 39(1): 41–49.PubMedCrossRef Heinz A, Epstein DH, Preston KL. Spiritual/religious experiences and in-treatment outcome in an inner-city program for heroin and cocaine dependence. Journal of Psychoactive Drugs 2007; 39(1): 41–49.PubMedCrossRef
48.
Zurück zum Zitat Mason SJ, Deane FP, Kelly PJ, et al. Do spirituality and religiosity help in the management of cravings in substance abuse treatment? Substance Use & Misuse 2009; 44(13): 1926–1940.CrossRef Mason SJ, Deane FP, Kelly PJ, et al. Do spirituality and religiosity help in the management of cravings in substance abuse treatment? Substance Use & Misuse 2009; 44(13): 1926–1940.CrossRef
49.
Zurück zum Zitat Conner BT, Anglin MD, Annon J, et al. Effect of religiosity and spirituality on drug treatment outcomes. The Journal of Behavioral Health Services and Research 2009; 36(2): 189–198.PubMedCentralPubMedCrossRef Conner BT, Anglin MD, Annon J, et al. Effect of religiosity and spirituality on drug treatment outcomes. The Journal of Behavioral Health Services and Research 2009; 36(2): 189–198.PubMedCentralPubMedCrossRef
50.
Zurück zum Zitat Carter T. The effects of spiritual practices on recovery from substance abuse. Journal of Psychiatric & Mental Health Nursing 1998; 5(5): 409–413.CrossRef Carter T. The effects of spiritual practices on recovery from substance abuse. Journal of Psychiatric & Mental Health Nursing 1998; 5(5): 409–413.CrossRef
51.
Zurück zum Zitat Stewart C. An empirical exploration of spirituality and religiousness in addiction treatment. American Journal of Pastoral Counseling 2004; 7(4): 71–83.CrossRef Stewart C. An empirical exploration of spirituality and religiousness in addiction treatment. American Journal of Pastoral Counseling 2004; 7(4): 71–83.CrossRef
52.
Zurück zum Zitat Spiegel MC, Kravitz RY. Confronting addiction. Jewish pastoral care: A practical handbook from traditional and contemporary sources 2001; 264–285. Spiegel MC, Kravitz RY. Confronting addiction. Jewish pastoral care: A practical handbook from traditional and contemporary sources 2001; 264–285.
53.
Zurück zum Zitat Green LL, Fullilove MT, Fullilove RE. Stories of spiritual awakening:: The nature of spirituality in recovery. Journal of Substance Abuse Treatment 1998; 15(4): 325–331.PubMedCrossRef Green LL, Fullilove MT, Fullilove RE. Stories of spiritual awakening:: The nature of spirituality in recovery. Journal of Substance Abuse Treatment 1998; 15(4): 325–331.PubMedCrossRef
54.
Zurück zum Zitat Zemore SE. A role for spiritual change in the benefits of 12 step involvement. Alcoholism: Clinical and Experimental Research 2007; 31 (s3): 76s-79s. Zemore SE. A role for spiritual change in the benefits of 12 step involvement. Alcoholism: Clinical and Experimental Research 2007; 31 (s3): 76s-79s.
56.
Zurück zum Zitat Connors GJ, Walitzer KS, Tonigan JS. Spiritual change in recovery. Recent Developments in Alcoholism 2009; 1–19. Connors GJ, Walitzer KS, Tonigan JS. Spiritual change in recovery. Recent Developments in Alcoholism 2009; 1–19.
57.
Zurück zum Zitat Sterling RC, Weinstein S, Losardo D, et al. A retrospective case control study of alcohol relapse and spiritual growth. The American Journal on Addictions 2007; 16(1): 56–61.PubMedCrossRef Sterling RC, Weinstein S, Losardo D, et al. A retrospective case control study of alcohol relapse and spiritual growth. The American Journal on Addictions 2007; 16(1): 56–61.PubMedCrossRef
59.
Zurück zum Zitat Koenig HG. Concerns about measuring "spirituality" in research. Journal of Nervous and Mental Disease 2008; 196(5): 349–355.PubMedCrossRef Koenig HG. Concerns about measuring "spirituality" in research. Journal of Nervous and Mental Disease 2008; 196(5): 349–355.PubMedCrossRef
60.
Zurück zum Zitat Dermatis H, James T, Galanter M, et al. An exploratory study of spiritual orientation and adaptation to therapeutic community treatment. Journal of addictive diseases 2010; 29(3): 306–313.PubMedCrossRef Dermatis H, James T, Galanter M, et al. An exploratory study of spiritual orientation and adaptation to therapeutic community treatment. Journal of addictive diseases 2010; 29(3): 306–313.PubMedCrossRef
61.
Zurück zum Zitat Simpson DD. A conceptual framework for drug treatment process and outcomes. Journal of Substance Abuse Treatment 2004; 27(2): 99–121.PubMedCrossRef Simpson DD. A conceptual framework for drug treatment process and outcomes. Journal of Substance Abuse Treatment 2004; 27(2): 99–121.PubMedCrossRef
62.
Zurück zum Zitat Hodge DR. A template for spiritual assessment: A review of the JCAHO requirements and guidelines for implementation. Social Work 2006; 51(4): 317–326.PubMedCrossRef Hodge DR. A template for spiritual assessment: A review of the JCAHO requirements and guidelines for implementation. Social Work 2006; 51(4): 317–326.PubMedCrossRef
63.
Zurück zum Zitat Galanter M, Dermatis H, Bunt G, et al. Assessment of spirituality and its relevance to addiction treatment. Journal of Substance Abuse Treatment 2007; 33(3): 257–264.PubMedCrossRef Galanter M, Dermatis H, Bunt G, et al. Assessment of spirituality and its relevance to addiction treatment. Journal of Substance Abuse Treatment 2007; 33(3): 257–264.PubMedCrossRef
64.
Zurück zum Zitat Miller WR, Forcehimes A, O'Leary MJ, et al. Spiritual direction in addiction treatment: Two clinical trials. Journal of Substance Abuse Treatment 2008; 35(4): 434–442.PubMedCentralPubMedCrossRef Miller WR, Forcehimes A, O'Leary MJ, et al. Spiritual direction in addiction treatment: Two clinical trials. Journal of Substance Abuse Treatment 2008; 35(4): 434–442.PubMedCentralPubMedCrossRef
65.
Zurück zum Zitat Simpson DD, Joe GW, Rowan-Szal GA, et al. Drug abuse treatment process components that improve retention. Journal of Substance Abuse Treatment 1997; 14(6): 565–572.PubMedCrossRef Simpson DD, Joe GW, Rowan-Szal GA, et al. Drug abuse treatment process components that improve retention. Journal of Substance Abuse Treatment 1997; 14(6): 565–572.PubMedCrossRef
66.
Zurück zum Zitat Joosten E, De Weert G, Sensky T, et al. Effect of shared decision-making on therapeutic alliance in addiction health care. Patient Preference and Adherence 2008; 2: 277–285. Joosten E, De Weert G, Sensky T, et al. Effect of shared decision-making on therapeutic alliance in addiction health care. Patient Preference and Adherence 2008; 2: 277–285.
67.
Zurück zum Zitat Poole R, Higgo R. Spirituality and the threat to therapeutic boundaries in psychiatric practice. Mental Health, Religion and Culture 2011; 14(1): 19–29.CrossRef Poole R, Higgo R. Spirituality and the threat to therapeutic boundaries in psychiatric practice. Mental Health, Religion and Culture 2011; 14(1): 19–29.CrossRef
68.
Zurück zum Zitat Cook CCH, Powell A, Sims A, et al. Spirituality and secularity: Professional boundaries in psychiatry. Mental Health, Religion and Culture 2011; 14(1): 35–42.CrossRef Cook CCH, Powell A, Sims A, et al. Spirituality and secularity: Professional boundaries in psychiatry. Mental Health, Religion and Culture 2011; 14(1): 35–42.CrossRef
69.
Zurück zum Zitat Meier PS, Donmall MC, McElduff P, et al. The role of the early therapeutic alliance in predicting drug treatment dropout. Drug and Alcohol Dependence 2006; 83(1): 57–64.PubMedCrossRef Meier PS, Donmall MC, McElduff P, et al. The role of the early therapeutic alliance in predicting drug treatment dropout. Drug and Alcohol Dependence 2006; 83(1): 57–64.PubMedCrossRef
70.
Zurück zum Zitat Meier PS, Barrowclough C, Donmall MC. The role of the therapeutic alliance in the treatment of substance misuse: A critical review of the literature. Addiction 2005; 100(3): 304–316.PubMedCrossRef Meier PS, Barrowclough C, Donmall MC. The role of the therapeutic alliance in the treatment of substance misuse: A critical review of the literature. Addiction 2005; 100(3): 304–316.PubMedCrossRef
71.
Zurück zum Zitat Brener L, Resnick I, Ellard J, et al. Exploring the role of consumer participation in drug treatment. Drug and Alcohol Dependence 2009; 105(1): 172–175.PubMedCrossRef Brener L, Resnick I, Ellard J, et al. Exploring the role of consumer participation in drug treatment. Drug and Alcohol Dependence 2009; 105(1): 172–175.PubMedCrossRef
Metadaten
Titel
A Preliminary 6-Month Prospective Study Examining Self-reported Religious Preference, Religiosity/Spirituality, and Retention at a Jewish Residential Treatment Center for Substance-Related Disorders
verfasst von
Iman Parhami, MD, MPH
Margarit Davtian, MA
Michael Collard, MA
Jean Lopez, BSc
Timothy W. Fong, MD
Publikationsdatum
01.07.2014
Verlag
Springer US
Erschienen in
The Journal of Behavioral Health Services & Research / Ausgabe 3/2014
Print ISSN: 1094-3412
Elektronische ISSN: 2168-6793
DOI
https://doi.org/10.1007/s11414-012-9279-x

Weitere Artikel der Ausgabe 3/2014

The Journal of Behavioral Health Services & Research 3/2014 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.